•
Sep 6, 2024
Sep 5, 2024
Aug 14, 2024
Aug 13, 2024
Aug 8, 2024
Aug 29, 2024
Aug 26, 2024
Sep 4, 2024
Aug 28, 2024
Aug 9, 2024
Pulmatrix, Inc. [PULM] has reported fiscal Q1 loss of $4.40 million.
On a per-share basis, the DE based company said its diluted earnings are $1.22.
The Pharmaceutical Preparations firm posted revenue of $1.50 million in this period.
Also Read: Pulmatrix Supports World Asthma Day 2023